DrugPatentWatch Database Preview
Drugs in Development Information for Quinacrine
» See Plans and Pricing
What is the drug development status for Quinacrine?
Quinacrine is an investigational drug.
There have been 9 clinical trials for Quinacrine.
The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2005.
The most common disease conditions in clinical trials are Lupus Erythematosus, Systemic, Prion Diseases, and Lupus Erythematosus, Cutaneous. The leading clinical trial sponsors are Cleveland BioLabs, Neelesh Sharma MD PhD, and Medical Research Council.
Summary for Quinacrine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,197 |
| WIPO Patent Applications | 13 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 3 (2005-01-01) |
| Vendors | 27 |
Recent Clinical Trials for Quinacrine
| Title | Sponsor | Phase |
|---|---|---|
| The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak | National Taiwan University Hospital | N/A |
| Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal ADenocarcinoma | Milton S. Hershey Medical Center | Phase 1/Phase 2 |
| Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer | Neelesh Sharma MD PhD | Phase 1 |
Clinical Trial Summary for Quinacrine
Top disease conditions for Quinacrine
Top clinical trial sponsors for Quinacrine
US Patents for Quinacrine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
